[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335122-105":59,"doc-detail-335122-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","the-prognostic-potential-of-mammographic-growth-rate-of-invasive-breast-cancer-in-the-nijmegen-breast-cancer-screening-cohort","The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort","","Objectives focus on whether specific growth rate (SGR) on screening mammograms can clarify tumor aggressiveness and improve recall decisions. Methods use a historic Nijmegen cohort of 293 women with invasive carcinoma of no special type, estimating tumor volumes on consecutive mammograms and comparing growth functions to derive SGR. Regression and multivariable survival analyses evaluate associations with prognostic factors and overall survival. Results show higher SGR aligns with a higher Nottingham prognostic index, unfavorable subtypes, and interval-cancer risk, while overall survival association is not significant after 12.4 years follow-up.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prognostic-potential-of-mammographic-growth-rate-of-invasive-breast-cancer-in-the-nijmegen-breast-cancer-screening-cohort/335122/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prognostic-potential-of-mammographic-growth-rate-of-invasive-breast-cancer-in-the-nijmegen-breast-cancer-screening-cohort/335122.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is specific growth rate (SGR) and why is it important in screening?","Question",{"text":112,"@type":113},"SGR is measured from tumor appearance on mammograms over time. It may help describe tumor aggressiveness so screening recall decisions can be optimized.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was SGR calculated in this study?",{"text":117,"@type":113},"Tumor volumes were estimated on consecutive mammograms, five growth functions were compared, and SGR was computed using the best-fitting function.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes were associated with higher SGR?",{"text":121,"@type":113},"Higher SGR increased the Nottingham prognostic index, raised the odds of an unfavorable subtype, and increased the odds of diagnosis as an interval cancer.",{"name":123,"@type":110,"acceptedAnswer":124},"Did SGR significantly predict overall survival?",{"text":125,"@type":113},"No. After a median of 12.4 years of follow-up, SGR was not associated with overall survival, and a potential link to cause-specific survival requires further research.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335122,1790196411,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort  \nJim Peters 1 , Jos A.A. M. van Dijck 1 , Sjoerd G. Elias2, Johannes D. M. Otten 1 , and Mireille J. M. Broeders 1,3  , on behalf of the IMAGINE Consortium  \nJ Med Screen  \n2024, Vol. 31(3) 166–175 © The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/09691413231222765](DOI: 10.1177/09691413231222765)[ ](DOI: 10.1177/09691413231222765)[journals.sagepub.com/home/msc](journals.sagepub.com/home/msc)  \nAbstract  \nObjectives: Insight into the aggressiveness of potential breast cancers found in screening may optimize recall decisions. Speciﬁc growth rate (SGR), measured on mammograms, may provide valuable prognostic information. This study addresses the association of SGR with prognostic factors and overall survival in patients with invasive carcinoma of no special type (NST) from a screened population.  \nMethods: In this historic cohort study, 293 women with NST were identiﬁed from all participants in the Nijmegen screening program (2003–2007). Information on clinicopathological factors was retrieved from patient ﬁles and follow-up on vital status through municipalities. On consecutive mammograms, tumor volumes were estimated. After comparing ﬁve growth functions, SGR was calculated using the best-ﬁtting function. Regression and multivariable survival analyses described associations between SGR and prognostic factors as well as overall survival.  \nResults: Each one standard deviation increase in SGR was associated with an increase in the Nottingham prognostic index by 0.34 [95% conﬁdence interval (CI): 0.21–0.46]. Each one standard deviation increase in SGR increased the odds of a tumor with an unfavorable subtype (based on histologic grade and hormone receptors; odds ratio 2.14 [95% CI: 1.45–3.15]) and increased the odds of diagnosis as an interval cancer (versus screen-detected; odds ratio 1.57 [95% CI: 1.20–2.06]). After a median of 12.4 years of follow-up, 78 deaths occurred. SGR was not associated with overall survival (hazard ratio 1.12 [95% CI: 0.87–1.43]). Conclusions: SGR may indicate prognostically relevant differences in tumor aggressiveness if serial mammograms are available. A potential association with cause-speciﬁc survival could not be determined and is of interest for future research.  \nKeywords  \nBreast cancer, growth rate, prognosis, survival, mammography, screening, cohort study  \nDate received: 7 September 2023; accepted: 15 November 2023  \nBackground  \nBreast cancer is a heterogeneous disease that can range from rather indolent to life-threatening.1–3 After a breast cancer diagnosis, detailed knowledge of its prognosis is essential to inform patients and make adequate therapeutic decisions.4 In screening, knowledge about tumor aggressiveness may help the timely detection of those tumors that would otherwise become lifethreatening and at the same time reduce the overdiagnosis of tumors that would cause no harm.5 In either a clinical or screening setting, the growth rate could be measured if serial mammograms, previously acquired in screening examinations, are available and may indicate differences in tumor aggressiveness.  \nMost existing prognostic models incorporate at least lymph node involvement, histologic grade, and tumor size.6 When a pathological assessment is not yet available, as in screening, tumor size could also be estimated from mammograms. Not all small tumors would become life-threatening larger tumors if left untreated, but some small tumors possess unfavorable  \nbiological characteristics and have a poor prognosis despite their size. Some large tumors with favorable biological features may have a better prognosis than small tumors of the unfavorable type.7  \nTherefore we need information beyond size to distinguish aggressive from indolent tumors. While histo","cbCaiaMunllaE9AL","https://ap.wps.com/l/cbCaiaMunllaE9AL","pdf",1265963,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusions\n# Background\n## Rationale for tumor aggressiveness assessment\n## Limits of existing prognostic models\n## Role of serial mammograms and growth rate\n# Method","[{\"question\":\"What is specific growth rate (SGR) and why is it important in screening?\",\"answer\":\"SGR is measured from tumor appearance on mammograms over time. It may help describe tumor aggressiveness so screening recall decisions can be optimized.\"},{\"question\":\"How was SGR calculated in this study?\",\"answer\":\"Tumor volumes were estimated on consecutive mammograms, five growth functions were compared, and SGR was computed using the best-fitting function.\"},{\"question\":\"What outcomes were associated with higher SGR?\",\"answer\":\"Higher SGR increased the Nottingham prognostic index, raised the odds of an unfavorable subtype, and increased the odds of diagnosis as an interval cancer.\"},{\"question\":\"Did SGR significantly predict overall survival?\",\"answer\":\"No. After a median of 12.4 years of follow-up, SGR was not associated with overall survival, and a potential link to cause-specific survival requires further research.\"}]","The prognostic potential of mammographic growth rate of invasive breast cancer in the Nijmegen breast cancer screening cohort | PDF",1790009736,25]